01—Abstract
Summary
Summary of the 10-Q filed May 8, 2025. Cited figures are marked; the original filing is the authoritative source.
Ecolab Inc. reported first-quarter 2025 results with net sales of $3,695.0 milliona, a 2% decrease compared to the prior year, primarily due to the divestiture of the global surgical solutions business and unfavorable currency translation.
However, on a fixed currency basis, net sales increased by 1%, and organic sales grew by 3%. The company's operating income saw a healthy increase of 7% to $555.3 millionb, driven by strong organic growth across its segments and improved pricing strategies. Net income attributable to Ecolab was $402.5 million, a slight decrease of 2% year-over-year, while diluted EPS stood at $1.41.
The company continues to make progress on its 'One Ecolab' initiative, which is designed to enhance growth and margin expansion, with significant restructuring charges impacting the current quarter. Despite these charges and ongoing macroeconomic uncertainties, Ecolab's diversified business model and focus on value pricing have supported its performance. Investors will be watching the execution of the 'One Ecolab' plan and its impact on future profitability and cash flow generation.
02—Key points
Key Highlights
- Net sales decreased 2% to $3,695.0 million, but organic sales increased by 3% year-over-year.
- Operating income increased 7% to $555.3 million, with organic operating income up 17%.
- Net income attributable to Ecolab decreased by 2% to $402.5 million ($1.41 diluted EPS).
- The company is progressing with its 'One Ecolab' restructuring initiative, incurring $39.4 million in charges during the quarter.
- Gross margin improved to 44.2% from 43.3% in the prior year, driven by strong value pricing.
- The Global Water segment reported a 3% increase in fixed currency sales and a 7% increase in fixed currency operating income.
- The company's revolving credit facility maturity was extended to March 2030, and it maintained a strong liquidity position with $1,162.6 million in cash and cash equivalents.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2025, Ecolab Inc. kept $0.11.
- Revenue$3.69B100.0%
- Cost of revenue−$2.06B55.8%
- Gross profit$1.63B44.2%
- Operating costs−$1.08B29.2%
- Operating income$555.3M15.0%
- Interest, other & tax−$152.8M4.1%
- Net income$402.5M10.9%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2025filed May 8, 2025Financial Statements
Q1 FY2025 against Q1 FY2024
| Line item | Q1 FY2025Q1 FY2024 | Change |
|---|---|---|
| Revenue | $3.69B$3.75B | −1.5% |
| Cost of Revenue | $2.06B$2.13B | −3.2% |
| Gross Profit | $1.63B$1.62B | +0.7% |
| SG&A Expenses | $1.05B$1.08B | −2.6% |
| Operating Income | $555.30M$517.90M | +7.2% |
| Interest Expense | $72.60M$94.50M | −23.2% |
| Net Income | $402.50M$412.10M | −2.3% |
| EPS (Basic) | $1.42$1.44 | −1.4% |
| EPS (Diluted) | $1.41$1.43 | −1.4% |
| Shares Outstanding (Basic) | 283.40M285.70M | −0.8% |
| Shares Outstanding (Diluted) | 285.30M287.80M | −0.9% |
05—Questions
Frequently Asked Questions
What was the main driver for the decrease in reported net sales?
The reported net sales decrease of 2% to $3,695.0 million was primarily driven by the divestiture of the global surgical solutions business and unfavorable currency translation effects.
How did the 'One Ecolab' initiative impact the quarter's results?
The 'One Ecolab' initiative led to $39.4 million in restructuring charges during the first quarter of 2025, primarily related to severance costs. While these charges impacted net income, the initiative is expected to enhance future growth and margin expansion.
What is Ecolab's liquidity position and outlook?
Ecolab maintains a strong liquidity position with $1,162.6 million in cash and cash equivalents as of March 31, 2025. The company also extended its revolving credit facility maturity to March 2030 and has ample borrowing capacity to meet its foreseeable needs.
How did Ecolab's different business segments perform?
Most segments showed positive organic growth. Global Water's fixed currency sales increased 3%, Global Institutional & Specialty's organic sales grew 4%, Global Pest Elimination's organic sales increased 5%, and Global Life Sciences' organic sales rose 5%. Operating income also saw increases in most segments on a fixed currency or organic basis.
06—Continue